Research & analysis · AlphaSense vs PitchBook
AlphaSense vs PitchBook: cost per seat, pricing and what each platform actually covers
Enter a ticker · read the research card · you decide
AI research card
Stocks · ETFs · Crypto · StartupsEnter any ticker to see a research card
Thesis, bull and bear case, key metrics, comparables and risk flags, synthesized into one structured tear-sheet.
Sample output is illustrative. Not financial advice.
Thesis
Bull case
Bear case
Key metrics
illustrative
Comparables
Risk flags
Informational only · sample output, not live market data · not financial advice.
PitchBook has a seat price you can check. AlphaSense does not. Four separate US federal contracts name a PitchBook license count, and dividing the award by the seats gives $7,000, $8,000, $8,412 and $10,500 per user per year. AlphaSense appears in the entire federal contract record exactly once, for BamSEC licenses bought by the Commerce Department in June 2025, with no dollar value disclosed.
That asymmetry is the most useful thing a buyer can know about these two vendors, and it is missing from every comparison we could find. The widely repeated "$10,000 to $20,000 per AlphaSense seat" is a reported range, not an audited one. Nobody has published a contract that confirms it. The PitchBook figures are arithmetic on documents anyone can pull up.
It also settles a claim AlphaSense makes on its own comparison page, that PitchBook requires six-figure annual retainers. Three of the five PitchBook subscriptions in the federal record are five-figure annual amounts: $91,000 for thirteen seats at Health and Human Services, about $51,250 a year for five seats at the Department of Labor, and $95,500 at Defense. Six figures is what a large deployment costs, not what PitchBook demands.
The products are less alike than the price comparison suggests. PitchBook is a structured private-markets database: investors, funds, deals, valuations and comparable transactions, sold per user per year on an annual contract. AlphaSense is a search and summarization layer over roughly 10,000 document sources plus the 200,000-plus expert call transcripts it acquired with Tegus for $930 million in July 2024. One tells you what a deal was worth. The other tells you what people said about it.
Investables.ai does neither job and is not pitched as a replacement for either. It is $29 to $249 a month and turns a ticker into a structured research card: what the business does, the metrics that matter in peer context, the bull case, the bear case, comparables and labeled risk flags. Public companies only, informational research, not investment advice.
Both sides bull and bear
Risk flags on every card
The short answer
What is the difference between AlphaSense and PitchBook?
PitchBook is a structured private-markets database covering investors, funds, deals and comparable transactions, priced per user per year. AlphaSense is a search layer over about 10,000 document sources plus 200,000-plus expert call transcripts, built to find what has been said rather than to tabulate what a deal was worth. On price, four US federal contracts put PitchBook seats between $7,000 and $10,500 a year. AlphaSense has published no price and appears in the federal record only once, with no dollar value.
Last updated August 2026
Why it works
Three things the contract record shows that the vendor comparison pages do not
One of these two has a seat price you can verify, and it is not the one you would guess
PitchBook sells to the US government often enough that its price is effectively public. Health and Human Services bought thirteen licenses for $91,000 across twelve months in FY2023, which is exactly $7,000 each. The Justice Department bought a twenty-one user standard platform subscription for $168,000 in FY2025, exactly $8,000 each. Its Financial Intelligence Unit bought seventeen user licenses for $143,000, about $8,412 each. The National Security Division bought fifteen for $157,500 in an award running from August 2026, exactly $10,500 each. The Department of Labor bought five licenses for $102,500 over a period running to September 2027, about $10,250 a seat a year. Five agencies, five arithmetic checks, one tight band. AlphaSense appears in that same record once, on a firm fixed price purchase of BamSEC licenses for the Commerce Department CHIPS Program Office signed on 27 May 2025, competed under simplified acquisition procedures, with no dollar figure in the public record. Every AlphaSense price you have read is somebody reporting a range, not somebody reading a contract.
The six-figure retainer claim does not survive the contract record
AlphaSense tells prospects on its own comparison page that it charges without annual retainers or minimum commitments while PitchBook requires six-figure annual retainers. The first half is a positioning claim we cannot test. The second half is testable and it is wrong as stated. Of the PitchBook subscriptions in the federal record, the Health and Human Services purchase was $91,000 a year, the Department of Labor purchase annualizes to about $51,250, and a Defense award signed in June 2026 was $95,500. All three are five-figure annual commitments for a named seat count. PitchBook contracts do reach six and seven figures: Defense signed a $2,024,667.50 two-year award in May 2025 and the State Department renewed at $719,822 for a single year. That is what scale costs at any vendor in this market, and AlphaSense enterprise deals are themselves reported at $50,000 to $100,000 and above, with some customers past $1 million. Read the claim as a statement about contract structure, not about the size of the check.
AlphaSense is moving off per-seat pricing, so what you negotiate is changing
AlphaSense crossed $700 million in annual recurring revenue in June 2026, up from roughly $540 million at the end of 2025, and was valued at $7.5 billion in the same month. Reporting from August 2026 has it shifting parts of its business away from flat per-seat annual licenses toward consumption-based billing as AI assistants move into Excel and PowerPoint. That matters at the negotiating table. A per-seat contract has one lever, the seat count, and you can model the bill exactly. A consumption contract has a rate, a committed volume and an overage price, and the risk moves onto you. If you are quoted on usage, ask for the overage rate in writing and a cap, and ask what happens to unused commitment at renewal. One useful sanity check on any quote: $700 million spread across the 7,000-plus enterprise customers AlphaSense reports implies well under $100,000 per customer on average, so a quote built on $40,000 seats is describing an outlier deployment, not the middle of the market.
What you get
A structured first pass on every name
Enter any ticker or asset and the research card synthesizes the thesis, lays out the bull and bear case, surfaces the key metrics and comparables, and flags the risks, so your own diligence starts further along.
- Turns any US ticker into a structured research card in seconds
- Costs $29 to $249 per month against roughly $7,000 to $20,000 per seat
- Puts the bull case and the bear case side by side with explicit risk flags
- Covers small and mid caps that get little or no sell-side coverage
- Needs no procurement cycle, no seat minimum and no annual commitment
- Sits alongside a PitchBook or AlphaSense contract rather than replacing it
Thesis
Dominant AI accelerator supplier. The debate is the durability of data-center demand versus a cyclical capex peak.
Bull
CUDA moat, near-monopoly share
Bear
Customer concentration, cycle risk
Side by side
AlphaSense vs PitchBook: price, disclosure and coverage from public records
Per-seat figures are our own arithmetic on US federal contract awards at USAspending.gov, retrieved 31 August 2026: award amount divided by the stated period of performance, then divided by the license count named in the award description. Federal prices are negotiated under procurement rules and are not list prices. Reported ranges are third-party and are labeled as such.
| What you are comparing | AlphaSense | PitchBook |
|---|---|---|
| Published US price list | None, quote only | None, quote only |
| Reported seat price, third party | About $10,000 to $20,000 a year, rising past $40,000 with expert transcript access | About $12,000 to $30,000 a year |
| Verified federal price per named seat | No figure exists anywhere in the record | $7,000, $8,000, $8,412 and $10,250 to $10,500 a year, from four separate awards |
| Cheapest seat on record | Not on record | $7,000 (Health and Human Services, 13 licenses, FY2023) |
| Dearest seat on record | Not on record | $10,500 (Justice, National Security Division, 15 licenses, awarded August 2026) |
| How many US federal awards name the vendor | One, for BamSEC licenses, with no dollar value disclosed | Fifteen or more, several naming an exact license count |
| Measured renewal escalator | Not measurable, no consecutive priced renewals exist | Exactly +20.00% at Health and Human Services, and +27.6% then +21.8% at State |
| Like-for-like seat price movement | Cannot be measured | $8,000 for 21 Justice seats in 2024 against $10,500 for 15 in 2026, on the same named product |
| Direction of the pricing model | Shifting off pure per-seat licensing toward consumption billing, reported August 2026 | Per user per year, annual contract, no monthly billing |
| Core content | About 10,000 document sources, plus 200,000-plus expert transcripts across 25,000 companies | 450,000-plus investors, 110,000-plus funds, private company deal and valuation records |
| Ownership | Independent. Valued at $7.5 billion in June 2026 | Morningstar, Inc. since 2016 |
| Investables.ai, for scale | $29 to $249 per month, published, no seat minimum | Same |
Derived per-seat figures establish order of magnitude and let you test whether a quote is out of line. They are not rate cards, and award descriptions sometimes understate scope. The absence of an AlphaSense figure is a finding about disclosure, not a claim that AlphaSense is expensive or cheap.
Why Investables.ai
One research card that compresses the reading
Not a wall of raw data, not a one-sided opinion, and not a six-figure terminal. The thesis, both sides of the argument and the risks, in one structured tear-sheet you can act on. You stay in control of every decision.
Both sides, every time
The bull case and the bear case sit side by side, so you weigh the argument instead of reading a single take. Informational only, never a recommendation.
Risks on the page
Valuation, concentration and regulatory risks are flagged explicitly, so the downside is visible up front rather than buried in a footnote.
Faster diligence
A structured first pass in seconds means you spend your time on judgement, not on gathering, across stocks, ETFs, crypto and startups.
Good questions
Questions about alphasense vs pitchbook
Explore more
More ways investors research with Investables.ai
AI investment research tool
Turn any ticker into a structured research card in seconds.
Learn moreAI stock analysis
Analyze any stock end to end without the manual grind.
Learn moreAI equity research
Sell-side-style equity research, generated on demand.
Learn moreAI financial analysis
Read a company's financials at a glance.
Learn moreAI ETF analysis
See what an ETF actually holds and what drives it.
Learn moreStock fundamental analysis software
Fundamentals, ratios and quality scores on any stock.
Learn moreResearch guides
How investors run this analysis by hand
- Should I Use AI to Pick Stocks? An Honest Answer Should you use AI to pick stocks? Not to choose them for you, but yes to research them faster. Here is the hon...
- What Is the Best AI for Investing? How to Judge the Tools What is the best AI for investing? Not the one that promises predictions. Here is how to judge AI investing to...
- How to Write a Stock Research Report (With a Simple Structure) How to write a stock research report that holds up: the six sections every report needs, what goes in each, an...
Start your research with one structured card
Enter any ticker or asset and read the thesis, both sides of the argument and the risk flags in seconds. Built to make your own diligence faster. You decide, every time.
Informational only, not financial advice · past performance does not guarantee future results